Immunomodulatory functions of microorganisms in tissue regenerative healing
Source abstract
Abstract
External pathogenic microorganisms and commensal microorganisms in the body have either harmful or beneficial impacts on the regenerative repair of tissues, and the immune system plays a crucial regulatory role in this process. This review summarises our current understanding of microorganism-immune system interactions, with a focus on how these interactions impact the renewal and repair ability of tissues, including skin, bone, gut, liver, and nerves. This review concludes with a discussion of the mechanisms by which microbes act on various types of immune cells to affect tissue regeneration, offers potential strategies for using microbial therapies to enhance the regenerative repair function of tissues, and suggest novel therapeutic approaches for regenerative medicine. STATEMENT OF SIGNIFICANCE: Microbiological communities have crucial impacts on human health and illness by participating in energy collection and storage and performing various metabolic processes. External pathogenic microorganisms and commensal microorganisms in the body have either harmful or beneficial impacts on the regenerative repair of tissues, and the immune system plays a critical regulatory role in this process. This study reviews the important correlation between microorganisms and the immune system and investigates the mechanism of various microorganism that participate in the regeneration and repair of tissues and organs by modulating immune system.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Cancer Research and Treatments · Mesenchymal stem cell research · Nerve injury and regeneration
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. The canine and feline skin microbiome in health and disease10.1111/j.1365-3164.2012.01076.x ↗
2. Ectopic colonization of oral bacteria in the intestine drives T(H)1 cell induction and inflammation10.1126/science.aan4526 ↗
3. Oral microbiomes: more and more importance in oral cavity and whole body10.1007/s13238-018-0548-1 ↗
4. Oral microbial dysbiosis and its performance in predicting oral cancer10.1093/carcin/bgaa062 ↗
5. The oral microbiome in health and its implication in oral and systemic diseases10.1016/bs.aambs.2016.08.002 ↗
6. Skin microbiota: a source of disease or defence?10.1111/j.1365-2133.2008.08437.x ↗
7. IL-33-dependent group 2 innate lymphoid cells promote cutaneous wound healing10.1038/JID.2015.406 ↗
8. Regulatory T cells protect from local and systemic bone destruction in arthritis10.4049/jimmunol.0903841 ↗
9. Lactobacillus acidophilus inhibits bone loss and increases bone heterogeneity in osteoporotic mice via modulating Treg-Th17 cell balance10.1016/j.bonr.2018.02.001 ↗
10. Novel perspectives on the role of the human microbiota in regenerative medicine and surgery10.3892/br.2016.778 ↗
11. Metagenomic analysis of the human distal gut microbiome10.1126/science.1124234 ↗
12. Gut microbiota, metabolites and host immunity10.1038/nri.2016.42 ↗
13. Pathogenesis and virulence of Candida albicans10.1080/21505594.2021.2019950 ↗
14. Candidalysin delivery to the invasion pocket is critical for host epithelial damage induced by Candida albicans
15. The human microbiome in sickness and in health10.1016/j.rce.2019.07.004 ↗
16. Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice10.3748/wjg.v11.i8.1131 ↗
17. Dysbiotic events in gut microbiota: impact on human health10.3390/nu6125786 ↗
18. Current understanding of dysbiosis in disease in human and animal models10.1097/MIB.0000000000000750 ↗
19. Interleukin-1β secretion induced by mucosa-associated gut commensal bacteria promotes intestinal barrier repair10.1080/19490976.2021.2014772 ↗
20. The gut-liver axis in health and disease: the role of gut microbiota-derived signals in liver injury and regeneration10.3389/fimmu.2021.775526 ↗
21. The microbiome and bone and joint disease10.1007/s11926-017-0705-1 ↗
22. The gut metabolite indole-3 propionate promotes nerve regeneration and repair10.1038/s41586-022-04884-x ↗
23. Non-classical immunity controls microbiota impact on skin immunity and tissue repair10.1016/j.cell.2017.12.033 ↗
24. What lives on our skin: ecology, genomics and therapeutic opportunities of the skin microbiome10.1016/j.ddmec.2012.12.003 ↗
25. Dysbiosis and staphylococcus aureus colonization drives inflammation in atopic dermatitis10.1016/j.immuni.2015.03.014 ↗
26. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens10.1016/j.jaci.2009.06.046 ↗
27. The human skin microbiome10.1038/nrmicro.2017.157 ↗
28. The evolution of the host microbiome as an ecosystem on a leash10.1038/nature23292 ↗
29. Maintenance of intestinal homeostasis by mucosal barriers10.1186/s41232-018-0063-z ↗
30. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity10.1038/nm.2087 ↗
31. Microbial colonization influences early B-lineage development in the gut lamina propria10.1038/nature12496 ↗
32. Microbial bile acid metabolites modulate gut RORγ(+) regulatory T cell homeostasis10.1038/s41586-019-1865-0 ↗
33. Butyrate: a double-edged sword for health?10.1093/advances/nmx009 ↗
34. The immune system and the gut microbiota: friends or foes?10.1038/nri2850 ↗
35. Human memory B cells in healthy gingiva, gingivitis, and periodontitis10.4049/jimmunol.1600540 ↗
36. Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils10.1111/j.0019-2805.2004.01816.x ↗
37. Interrelation of immunity and tissue repair or regeneration10.1016/j.semcdb.2009.04.009 ↗
38. The effects of graphene and mesenchymal stem cells in cutaneous wound healing and their putative action mechanism10.2147/IJN.S190928 ↗
39. Wound healing: a cellular perspective10.1152/physrev.00067.2017 ↗
40. Clinical application of growth factors and cytokines in wound healing10.1111/wrr.12205 ↗
41. Langerhans cells - the macrophage in dendritic cell clothing10.1016/j.it.2017.06.008 ↗
42. Inflammation and wound healing: the role of the macrophage10.1017/S1462399411001943 ↗
43. Advances of stem cell therapeutics in cutaneous wound healing and regeneration10.1155/2017/5217967 ↗
44. The role of the extracellular matrix components in cutaneous wound healing10.1155/2014/747584 ↗
45. Macrophage differentiation in normal and accelerated wound healing10.1007/978-3-319-54090-0_14 ↗
46. Macrophages in tissue repair, regeneration, and fibrosis10.1016/j.immuni.2016.02.015 ↗
47. Macrophage phenotypes regulate scar formation and chronic wound healing10.3390/ijms18071545 ↗
48. Immune- and non-immune-mediated roles of regulatory T-cells during wound healing10.1111/imm.13057 ↗
49. Repair' Treg cells in tissue injury10.1159/000484295 ↗
50. The commensal skin microbiota triggers type I IFN-dependent innate repair responses in injured skin10.1038/s41590-020-0721-6 ↗
51. Non-classical immunity controls microbiota impact on skin immunity and tissue repair10.1016/j.cell.2017.12.033 ↗
52. Gut-skin axis: current knowledge of the interrelationship between microbial dysbiosis and skin conditions10.3390/microorganisms9020353 ↗
53. Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin10.1371/journal.pone.0078898 ↗
54. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota10.1073/pnas.0909122107 ↗
55. Intestinal microbiota promotes psoriasis-like skin inflammation by enhancing Th17 response10.1371/journal.pone.0159539 ↗
56. Immune modulation property of Lactobacillus paracasei NCC2461 (ST11) strain and impact on skin defences10.3920/BM2013.0014 ↗
57. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies10.1016/j.jaci.2017.01.011 ↗
58. Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization10.1186/s40168-018-0533-1 ↗
59. Corynebacterium contextual control of skin immunity and inflammation by10.1084/jem.20171079 ↗
60. Propionibacterium acnes: an update on its role in the pathogenesis of acne10.1111/jdv.12224 ↗
61. The microbiological landscape of anaerobic infections in hidradenitis suppurativa: a prospective metagenomic study10.1093/cid/cix285 ↗
62. Hidradenitis suppurativa is characterized by dysregulation of the Th17:treg cell axis, which is corrected by anti-TNF therapy10.1016/j.jid.2017.05.033 ↗
63. Pseudomonas aeruginosa flagellum is critical for invasion, cutaneous persistence and induction of inflammatory response of skin epidermis10.1080/21505594.2018.1480830 ↗
64. The pathogen Candida albicans hijacks pyroptosis for escape from macrophages10.1128/mBio.00003-14 ↗
65. Osteoclast-Induced immunosuppression occurs through dysregulation of immune checkpoint axes in multiple myeloma10.1182/blood-2019-130462 ↗
66. Harnessing and modulating inflammation in strategies for bone regeneration10.1089/ten.teb.2011.0182 ↗
67. The biology of fracture healing10.1016/j.injury.2011.03.031 ↗
68. A perspective on immunomodulation and tissue repair10.1007/s10439-013-0941-0 ↗
69. Inflammation and biomaterials: role of the immune response in bone regeneration by inorganic scaffolds10.1039/D0TB01379J ↗
70. Human CD4+CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells10.1016/j.bbrc.2007.04.042 ↗
71. Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss10.1038/s41467-017-02490-4 ↗
72. Probiotics protect mice from CoCrMo particles-induced osteolysis10.2147/IJN.S130485 ↗
73. Lactobacillus rhamnosus attenuates bone loss and maintains bone health by skewing Treg-Th17 cell balance in Ovx mice10.1038/s41598-020-80536-2 ↗
74. Probiotic Lactobacillus rhamnosus GG prevents alveolar bone loss in a mouse model of experimental periodontitis10.1111/jcpe.12838 ↗
75. Lactobacillus rhamnosus GG attenuates interferon-{gamma} and tumour necrosis factor-alpha-induced barrier dysfunction and pro-inflammatory signalling10.1099/mic.0.040139-0 ↗
76. Beneficial effects of Lactobacillus reuteri 6475 on bone density in male mice is dependent on lymphocytes10.1038/s41598-019-51293-8 ↗
77. Lactobacillus acidophilus inhibits bone loss and increases bone heterogeneity in osteoporotic mice via modulating Treg-Th17 cell balance10.1016/j.bonr.2018.02.001 ↗
78. Preventive effect of Lactobacillus helveticus SBT2171 on collagen-induced arthritis in mice10.3389/fmicb.2017.01159 ↗
79. B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity10.4049/jimmunol.179.2.1369 ↗
80. Bifidobacterium longum ameliorates ovariectomy-induced bone loss via enhancing anti-osteoclastogenic and immunomodulatory potential of regulatory B cells (Bregs)10.3389/fimmu.2022.875788 ↗
81. Bacillus clausii inhibits bone loss by skewing Treg-Th17 cell equilibrium in postmenopausal osteoporotic mice model10.1016/j.nut.2018.02.013 ↗
82. regulates proinflammatory immune response in mouse macrophages via activating the MAPK, AKT, and NF-κB pathways10.1631/jzus.B2100456 ↗
83. Outer membrane vesicles from fusobacterium nucleatum switch M0-like macrophages toward the M1 phenotype to destroy periodontal tissues in mice10.3389/fmicb.2022.815638 ↗
84. The pathogenic effects of fusobacterium nucleatum on the proliferation, osteogenic differentiation, and transcriptome of osteoblasts10.3389/fcell.2020.00807 ↗
85. Role of T cells in ovariectomy induced bone loss–revisited10.1002/jbmr.1500 ↗
86. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells10.1016/j.immuni.2010.06.001 ↗
87. Identification of stem cells in small intestine and colon by marker gene Lgr510.1038/nature06196 ↗
88. The cytosolic bacterial peptidoglycan sensor Nod2 affords stem cell protection and links microbes to gut epithelial regeneration10.1016/j.chom.2014.05.003 ↗
89. Lactobacillus accelerates ISCs regeneration to protect the integrity of intestinal mucosa through activation of STAT3 signaling pathway induced by LPLs secretion of IL-2210.1038/s41418-018-0070-2 ↗
90. Lactobacillus reuteri induces gut intraepithelial CD4(+)CD8αα(+) T cells10.1126/science.aah5825 ↗
91. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-2210.1016/j.immuni.2013.08.003 ↗
92. Immunomodulation of dendritic cells by Lactobacillus reuteri surface components and metabolites10.14814/phy2.14719 ↗
93. Microbes affect gut epithelial cell composition through immune-dependent regulation of intestinal stem cell differentiation10.1016/j.celrep.2022.110572 ↗
94. Spatio-temporal expression of tryptophan hydroxylase isoforms in murine and human brain: convergent data from Tph2 knockout mice10.1016/j.euroneuro.2008.12.005 ↗
95. Gut microbiota drives macrophage-dependent self-renewal of intestinal stem cells via niche enteric serotonergic neurons10.1038/s41422-022-00645-7 ↗
96. Gut microbiota: microbiota promote gut healing10.1038/nrgastro.2016.31 ↗
97. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis10.1016/j.cell.2004.07.002 ↗
98. Interactions between the microbiota and innate and innate-like lymphocytes10.1002/JLB.3RI0917-378R ↗
99. Intestinal bacteria induce TSLP to promote mutualistic T-cell responses10.1038/mi.2013.12 ↗
100. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota10.1126/science.1206095 ↗